✦ LIBER ✦

Pharmacokinetics of rosoxacin in human volunteers

✍ Scribed by G. B. Park; J. Saneski; T. Weng; J. Edelson

Publisher: John Wiley and Sons
Year: 1982
Tongue: English
Weight: 214 KB
Volume: 71
Category: Article
ISSN: 0022-3549
DOI: 10.1002/jps.2600710424

No coin nor oath required. For personal study only.

✦ Synopsis

Reversed-phase liquid chromatography was used to determine plasma rosoxacin concentrations in normal, healthy males, each of whom received one 300 mg capsule of rosoxacin. The plasma data for each subject were described by an open one-compartment body model with first-order absorption, and the pharmacokinetic parameters were determined. The mean ( k S E ) apparent first-order terminal elimination rate constant was 0.203 f 0.015 hr-' ( N = 16), the mean apparent volume of distribution was 0.644 f 0.050 litedkg, and the mean apparent plasma clearance was 2.08 f 0.15 ml/min/kg.

📜 SIMILAR VOLUMES

Repeated dose pharmacokinetics of pancop

Repeated dose pharmacokinetics of pancopride in human volunteers

✍ P. Salva; J. Costa; A. Perez-Campos; Dr A. Martinez-Tobed 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 421 KB 👁 2 views

The aim of this study was to assess the pharmacokinetic profile of pancopride after repeated oral dose administration of 20mg pancopride in tablet form once a day for 5 d in 12 healthy male volunteers. Plasma levels were measured by HPLC using a solid phase extraction method and automated injection.

Oral and intravenous pharmacokinetics of

Oral and intravenous pharmacokinetics of milrinone in human volunteers

✍ Ronald M. Stroshane; Raymond F. Koss; Charles E. Biddlecome; Carol Luczkowec; Je 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 370 KB

Pharmacokinetics, metabolism and excreti

Pharmacokinetics, metabolism and excretion of intravenous [l4C]-palonosetron in healthy human volunteers

✍ Randall Stoltz; Simona Parisi; Ajit Shah; Alberto Macciocchi 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 2 views

Pharmacokinetics and bioavailability of

Pharmacokinetics and bioavailability of oral ergometrine in male volunteers

✍ A. N. J. A. De Groot; T. B. Vree; Y. A. Hekster; M. Van Den Biggelaar-Martea; P. 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 380 KB 👁 2 views

The aim of this investigation was to assess the pharmacokinetics and bioavailability of ergometrine in six human male subjects after an oral dose of 0.200 mg and after an intravenous dose of 0.075 mg of ergometrine maleate. A large variation in bioavailability of between 34% and 117% in the six volu

Pharmacokinetics of minoxidil in patient

Pharmacokinetics of minoxidil in patients with cirrhosis and healthy volunteers

✍ Marijke H. Adams; Wesley J. Poynor; William R. Garnett; H. T. Karnes; James J. F 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 246 KB 👁 2 views

Objectives: To determine the effect of reduced hepatic function on the pharmacokinetics of minoxidil. The pharmacokinetics of antipyrine, lorazepam, and indocyanine green were included as indicators of hepatic function. Methods: Eight mild cirrhotics and eight healthy subjects received antipyrine (p

Single dose pharmacokinetics and bioavai

Single dose pharmacokinetics and bioavailability of nevirapine in healthy volunteers

✍ Michael J. Lamson; John P. Sabo; Thomas R. Macgregor; Joseph W. Pav; Lois Rowlan 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 170 KB 👁 2 views

The results of two randomized, single-dose, crossover bioavailability studies are presented which describe the pharmacokinetics and oral bioavailability of nevirapine, a novel nonnucleoside antiretroviral drug. In the first study 12 healthy male volunteers received nevirapine 15 mg via short-term i.